Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Adverse HF Outcomes in Persons Living with HIV

Am Heart J; ePub 2019 Jan 11; Alvi, Afshar, et al

There is an increased 30-day heart failure (HF) readmission rate among persons living with HIV (PLHIV), a new study found. The cohort included 2,308 individuals admitted to a US tertiary medical center with decompensated HF. Researchers compared baseline characteristics, 30-day HF readmission, cardiovascular (CV), and all-cause mortality among PLHIV with HF vs individuals without HIV with HF. They found:

  • There were 374 (16%) PLHIV with HF; groups were similar with respect to age, sex, race/ethnicity, and CV risk factors.
  • PLHIV had increased 30-day HF readmission, CV, and all-cause mortality rates.
  • Conversely, PLHIV with a higher CD4 count and undetectable viral load (VL) had similar HF outcomes to uninfected controls.

Citation:

Alvi RM, Afshar M, Neilan AM, et al. Heart failure and adverse heart failure outcomes among persons living with HIV in a US tertiary medical center. [Published online ahead of print January 11, 2019]. Am Heart J. doi:10.1016/j.ahj.2019.01.002.